Valuation: WntResearch AB

Market Cap 128M 13.22M 11.61M 10.8M 9.91M 18.62M 1.27B 18.91M 50.1M 626M 49.63M 48.56M 2.16B P/E 2024 *
-
P/E 2025 -4.79x
Enterprise Value 128M 13.24M 11.63M 10.81M 9.92M 18.65M 1.28B 18.93M 50.17M 627M 49.71M 48.63M 2.17B EV / Sales 2024 *
-
EV / Sales 2025 8,542,354x
Free-Float
1.03%
Yield 2024 *
-
Yield 2025 -
Change 5-day change 1-year change 3-year change Capi.($)
+3.35%-13.20% - - 13.13M
-1.92%-1.57%+48.70%+84.37% 55.92B
+0.93%+6.97%+62.83%+67.97% 56.67B
-2.53%-2.07%-21.80%-16.29% 23.28B
-0.40%-0.96%+3.63%+424.34% 23.28B
-0.36%-0.56%+36.00%-3.93% 20.54B
-1.34%+0.51%+25.02%-30.27% 17.78B
-1.44%-1.63%+37.07%+589.93% 15.9B
-1.30%-9.92%+160.67%+284.37% 14.64B
-0.35%-0.73%+23.93%+179.08% 13.99B
Average -0.56%+0.47%+41.78%+175.51% 26.89B
Weighted average by Cap. -0.86%+1.47%+42.65%+138.42%

Financials

2024 2025
Net sales - 9.68 1 0.88 0.82 0.75 1.41 96.14 1.43 3.78 47.27 3.75 3.67 163.42
Net income -46.5M -4.79M -4.21M -3.92M -3.59M -6.75M -462M -6.86M -18.17M -227M -18M -17.61M -785M -17.23M -1.78M -1.56M -1.45M -1.33M -2.5M -171M -2.54M -6.73M -84.11M -6.67M -6.53M -291M
Net Debt -5.26M -542K -476K -443K -406K -763K -52.21M -775K -2.05M -25.67M -2.04M -1.99M -88.74M 185K 19.07K 16.75K 15.58K 14.3K 26.86K 1.84M 27.28K 72.28K 903K 71.6K 70.06K 3.12M
Logo WntResearch AB
Opsy Holding AB, formerly WntResearch AB, is a Sweden-based company engaged in the translational cancer research. Its aim is to develop anti-metastatic therapies based on an increased understanding of the mechanisms underlying the metastatic process and the evaluation of specific small molecules that can specifically interact with this process. The Company’s programs focus on the role of the Wnt-5a protein in the metastatic process.
Employees
7